Case Report: Neurodevelopmental Outcome in a Small-for-Gestational-Age Infant With Symptomatic Hyperinsulinemic

Suresh Chandran1,2,3,4, Kok Wooi Teoh1, Krishnappa Janardhan2,3,4,5

  • 1Department of Neonatology, KK Women's and Children's Hospital, Singapore, Singapore.

Insights

Severe hypoglycemia in small-for-gestational-age infants can cause brain injury and infantile spasms. Early diagnosis and treatment of hyperinsulinemic hypoglycemia and associated neurological symptoms are crucial for better outcomes.

Area of Science:

  • Neonatal neurology
  • Endocrinology
  • Pediatric epilepsy

Background:

  • Recurrent hypoglycemia is a major cause of neonatal brain injury.
  • Small-for-gestational-age infants are susceptible due to substrate deficiency and hyperinsulinism.
  • Hypoglycemic neuronal injury is a suspected trigger for infantile spasms, with unclear mechanisms.

Observation:

  • A term, small-for-gestational-age male infant presented with severe symptomatic hypoglycemia requiring high glucose infusion.
  • Diagnostic tests revealed inappropriate insulin levels during hypoglycemia, confirming hyperinsulinemic hypoglycemia.
  • The infant developed left gaze preference, followed by electroencephalogram-confirmed infantile spasms.

Findings:

  • Hyperinsulinemic hypoglycemia was successfully managed with diazoxide and gradual weaning of glucose infusion.
  • Infantile spasms were controlled with high-dose prednisolone therapy.
  • At age 6, the patient exhibits mild fine motor delay and learning disabilities.

Implications:

  • Early identification of gaze preference as a potential indicator of occipital lobe epilepsy is vital.
  • Prompt EEG monitoring and treatment for suspected epileptic activity may prevent infantile spasms.
  • Timely intervention in neonatal hypoglycemia and subsequent neurological complications can improve long-term prognosis.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
239
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
332